Silence Therapeutics plc Revenue From Contracts With Customers
Silence Therapeutics plc (SLNCF) reported Revenue From Contracts With Customers of GBP 25.38 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Income Statement › Other Income
ifrs-full:RevenueFromContractsWithCustomers · last filed 2024-03-13
| Period end | Revenue From Contracts With Customers 12 month |
|---|---|
| 2023-12-31 | 25.38M GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | 17.50M GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | 12.41M GBP 20-F · filed 2024-03-13 |
| 2020-12-31 | 5.48M GBP 20-F · filed 2023-03-15 |
| 2019-12-31 | 244.00K GBP 20-F · filed 2022-03-17 |